Jump to content
Powered by
  • BIOPRO BW
  • Healthcare industry
  • Bioeconomy

Bioeconomy

Main navigation

  • Start page
  • Bioeconomy in BW

    Bioeconomy in BW

    Close
    • What is a bioeconomy?
      • Perspectives on the bioeconomy
      • Processes and technologies in the bioeconomy
      • Bioeconomy products
    • Bioeconomy in BW
      • Start-up funding
    • Bioeconomy stakeholders in BW
      • BW and its companies
      • BW and its researchers
      • BW and its networks
  • Articles

    Articles

    Close
    • News
    • Press releases
    • Dossiers
    • Biobased resources
    • Bioenergy
    • Materials and chemicals
    • Politics, ethics & economy
    • Environmental analytics
    • Publications
  • Events

    Events

    Close
  • Databases

    Databases

    Close
    • Funding
    • Research institutions
  • BIOPRO services

    BIOPRO services

    Close
    • Information channels
    • Contacts
    • BIOPRO services and offers
  • de
  • en
Show menu

You are here:

  1. Home
  2. Search
Show:Results per page
  • 25Show results
  • 50Show results
  • 75Show results

Search Results

  • Biosensors - 03/12/2019 Abb1_System.jpg

    Learning from honey bees

    Biosensors are used in medical diagnostics and food and environmental analyses, to name just a few examples. apic.ai, a start-up based in Karlsruhe, uses honey bees as bioindicators to gain insights into the state of the ecosystem. The company also uses artificial intelligence (AI) methods for their ecotoxicological investigations.

    https://www.biooekonomie-bw.de/en/articles/news/learning-from-the-bees
  • Article - 10/01/2019 Cover of the fourth gene technology report.

    Stocktaking and recommendations for action: the BBAW’s fourth gene technology report

    In the new gene technology report, the interdisciplinary working group of the Berlin-Brandenburg Academy of Sciences (BBAW) takes stock of gene technology developments in Germany during the past few decades, and discusses the societal, legal and ethical challenges associated with these technologies in the future. The report is highly topical due to the controversy surrounding the ruling of the European Court of Justice on CRISPR/Cas9 genome…

    https://www.biooekonomie-bw.de/en/articles/news/stocktaking-and-recommendations-for-action-the-bbaws-fourth-gene-technology-report
  • Press release - 30/04/2013 19630_de.jpg

    Impressions from the 2013 BIO International Convention in Chicago

    A trade fair turns 20 and an industrial sector is coming of age. Where does BIO stand today? The number of exhibitors has slightly decreased the conference is characterised by general themes and trends and partnering has become the most important and indispensable part of the global event for biotechnology. What was once a gold rush atmosphere has given way to an experienced self-confidence about the economic importance of biotechnology.

    https://www.biooekonomie-bw.de/en/articles/pm/impressions-from-the-2013-bio-international-convention-in-chicago
  • Dossier - 25/03/2013 19401_de.jpg

    Biotechnology goes automated

    Processes that previously required pipetting analysis and production to be carried out manually are increasingly now controlled by automated systems. However this has not necessarily involved a complete reinvention of the wheel instead automation systems used in the plant construction and mechanical engineering sectors are being adapted and optimised for application in the life sciences.

    https://www.biooekonomie-bw.de/en/articles/dossiers/biotechnology-goes-automated
  • Article - 15/10/2012 18369_de.jpg

    gerbion®: hunting down pathogens

    Detecting viruses, bacteria or parasites in human, animal, food and environmental samples is routine for the staff of gerbion GmbH & Co. KG. The company has been using virological, microbiological and serological methods for many years, but is now also using cutting-edge molecular biology methods for detecting pathogens. The founders of the Kornwestheim-based diagnostics company have concentrated on own research work and the development of…

    https://www.biooekonomie-bw.de/en/articles/news/gerbion-hunting-down-pathogens
  • Article - 06/02/2012 16295_de.jpg

    Ten outstanding ideas in biotechnology and medical technology

    The results of the feasibility studies funded under the Idea Competition in Biotechnology and Medical Technology were presented in the Haus der Wirtschaft in Stuttgart between 16th and 18th January 2012. Ten of the 42 project ideas were recommended for further funding.

    https://www.biooekonomie-bw.de/en/articles/news/ten-outstanding-ideas-in-biotechnology-and-medical-technology
  • Dossier - 18/10/2010 The photo shows a sequencing laboratory at GATC whose employees operate big sequencing systems.<br />

    New machines for the life sciences

    Hardware and software applications have become an integral part of the everyday life of life sciences researchers, developers and service providers. It is impossible to imagine life science applications without effective hardware and software applications – from computer-assisted drug screening to the automatic production of biosensors for rapid, mobile, purse-size bacterial test devices. Trends such as automation and miniaturisation lead to ever…

    https://www.biooekonomie-bw.de/en/articles/dossiers/new-machines-for-the-life-sciences
  • Article - 28/06/2010 The schematic shows a protein complex with different areas.<br />

    ATG:biosynthetics GmbH – Modular molecular systems of the future

    ATGbiosynthetics GmbH based in Merzhausen close to Freiburg produces biological systems that can combine gene constituents following a construction kit principle. The company provides the pharmaceutical industry and basic researchers with products that have specifically chosen properties.

    https://www.biooekonomie-bw.de/en/articles/news/atg-biosynthetics-gmbh-modular-molecular-systems-of-the-future
  • Dossier - 16/07/2009 09218_de.jpg

    Patents – the exploitations of inventions in the life sciences

    According to statistics from the European Patent Office a total of 1065 biotechnological patents were filed in 2007 by inventors based in Germany. This puts Germany second behind the USA. In the coming years experts expect that a much larger number of biotech patents will be filed. For life sciences inventors the registration of patents quite often represents a real challenge. People entering the world of patents and licences are faced with a…

    https://www.biooekonomie-bw.de/en/articles/dossiers/patents-the-exploitations-of-inventions-in-the-life-sciences
  • Article - 09/06/2009 08813_de.jpg

    We would gladly finance more biotechs

    For four years, the High-Tech Gründerfonds (high-tech company establishment fund) has been supporting technology-oriented company founders. The project, which is backed by the Federal German government and major businesses, has 272 million euros of largely federal funds at its disposal, and its objective is the accelerated marketability of ideas. We spoke with Marco Winzer, representative and Investment Director at High-Tech Gründerfonds,…

    https://www.biooekonomie-bw.de/en/articles/news/we-would-gladly-finance-more-biotechs
  • Article - 18/05/2009 People who eat fruit in order to be healthy and beautiful find it somewhat disturbing to be reminded of cellulite in the form of “Alexander Lucas” pears.

    Less chemistry and fresher fruits and vegetables

    At Lake Constance fruit growers have bigger problems to face than ideological discussions on biotechnology and genetic engineering. They need methodological solutions for devastating plant diseases that would help them reduce the use of chemicals.

    https://www.biooekonomie-bw.de/en/articles/news/less-chemistry-and-fresher-fruits-and-vegetables
  • Article - 09/06/2008 At first, there was a lot of demand for small production batches; the picture shows a 250-l fermenter (Photo: Rentschler Biotechnologie)

    Moderate growth

    In 2007 the German biotechnology sector was marked by moderate growth. Turnover climbed over two billion euros and research and development expenditure reached one billion euros. These are the central findings of the latest company survey carried out by biotechnologie.de.

    https://www.biooekonomie-bw.de/en/articles/news/moderate-growth
  • Press release - 26/04/2008

    Curetis AG - Compact weapon against tuberculosis

    In conjunction with reference laboratories of the World Health Organization WHO medtech company Curetis AG is developing new technologies and products that identify the pathogens of infectious diseases such as tuberculosis and their resistance. The solutions are impressive.

    https://www.biooekonomie-bw.de/en/articles/pm/curetis-ag-compact-weapon-against-tuberculosis
  • Extend search to all portals
  • Search the Healthcare industry database
  • Search the Research institutions
Search terms
Portal
Information type
  • Type
    Event date
    From
    To
  • Type
  • Publication date
    Topics
    Topics
  • Publication date
Reset

Footer navigation

  • Bioeconomy in BW
    • What is a bioeconomy?
    • Bioeconomy in BW
    • Bioeconomy stakeholders in BW
  • Articles
    • News
    • Press releases
    • Dossiers
    • Biobased resources
    • Bioenergy
    • Materials and chemicals
    • Politics, ethics & economy
    • Environmental analytics
    • Publications
  • Events
  • Databases
    • Funding
    • Research institutions
  • BIOPRO services
    • Information channels
    • Contacts
    • BIOPRO services and offers
  • Project pages
    • Telemedicine BW
    • MDR & IVDR
  • Portals
    • BIOPRO BW
    • Healthcare industry
    • Bioeconomy
  • To top

stay informed

Subscribe to newsletter

Social Media

  • Xing
  • Twitter
  • LinkedIn
  • Rss
  • Privacy statement
  • Legal notice
  • Sitemap
  • Contact
© 2022
Website address: https://www.biooekonomie-bw.de/en/search